Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Studies of cases of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) confirmed by multiplex ligation-dependent probe amplification (MLPA) have determined the clinical characteristics, genotype, and relations between the reading frame and phenotype for different countries. This is the first such study from India. Methods A retrospective genotype-phenotype analysis of 317 MLPA-confirmed patients with DMD or BMD who visited the neuromuscular clinic of a quaternary referral center in southern India. Results The 317 patients comprised 279 cases of DMD (88%), 32 of BMD (10.1%), and 6 of intermediate phenotype (1.9%). Deletions accounted for 91.8% of cases, with duplications causing the remaining 8.2%. There were 254 cases of DMD (91%) with deletions and 25 (9%) due to duplications, and 31 cases (96.8%) of BMD with deletions and 1 (3.2%) due to duplication. All six cases of intermediate type were due to deletions. The most-common mutation was a single-exon deletion. Deletions of six or fewer exons constituted 68.8% of cases. The deletion of exon 50 was the most common. The reading-frame rule held in 90% of DMD and 94% of BMD cases. A tendency toward a lower IQ and earlier wheelchair dependence was observed with distal exon deletions, though a significant correlation was not found. Conclusions The reading-frame rule held in 90% to 94% of children, which is consistent with reports from other parts of the world. However, testing by MLPA is a limitation, and advanced sequencing methods including analysis of the structure of mutant dystrophin is needed for more-accurate assessments of the genotype-phenotype correlation.
Abstract
Background and Purpose Studies of cases of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) confirmed by multiplex ligation-dependent probe amplification (MLPA) have determined the clinical characteristics, genotype, and relations between the reading frame and phenotype for different countries. This is the first such study from India. Methods A retrospective genotype-phenotype analysis of 317 MLPA-confirmed patients with DMD or BMD who visited the neuromuscular clinic of a quaternary referral center in southern India. Results The 317 patients comprised 279 cases of DMD (88%), 32 of BMD (10.1%), and 6 of intermediate phenotype (1.9%). Deletions accounted for 91.8% of cases, with duplications causing the remaining 8.2%. There were 254 cases of DMD (91%) with deletions and 25 (9%) due to duplications, and 31 cases (96.8%) of BMD with deletions and 1 (3.2%) due to duplication. All six cases of intermediate type were due to deletions. The most-common mutation was a single-exon deletion. Deletions of six or fewer exons constituted 68.8% of cases. The deletion of exon 50 was the most common. The reading-frame rule held in 90% of DMD and 94% of BMD cases. A tendency toward a lower IQ and earlier wheelchair dependence was observed with distal exon deletions, though a significant correlation was not found. Conclusions The reading-frame rule held in 90% to 94% of children, which is consistent with reports from other parts of the world. However, testing by MLPA is a limitation, and advanced sequencing methods including analysis of the structure of mutant dystrophin is needed for more-accurate assessments of the genotype-phenotype correlation.
참고문헌 (35)
- Bushby K, "Diagnosis and management of Duchenne muscular dystrophy, part 1:diagnosis, and pharmacological and psychosocial management", Lancet Neurol, 9, pp.77~93 (2010)
- Bushby KM, "Prevalence and incidence of Becker muscular dystrophy", Lancet, 337, pp.1022~1024 (1991)
- Monaco AP, "Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene", Nature, 323, pp.646~650 (1986)
- Hoffman EP, "Subcellular fractionation of dystrophin to the triads of skeletal muscle", Nature, 330, pp.754~758 (1987)
- Blake DJ, "Function and genetics of dystrophin and dystrophin-related proteins in muscle", Physiol Rev, 82, pp.291~329 (2002)
- Muntoni F, "Dystrophin and mutations: one gene, several proteins, multiple phenotypes", Lancet Neurol, 2, pp.731~740 (2003)
- Hoffman EP, "Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne’s or Becker’s muscular dystrophy", N Engl J Med, 318, pp.1363~1368 (1988)
- Nicholson LV, "Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy", Acta Neuropathol, 80, pp.239~250 (1990)
- Monaco AP, "An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus", Genomics, 2, pp.90~95 (1988)
- Aartsma-Rus A, "Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule", Muscle Nerve, 34, pp.135~144 (2006)
- Yang J, "MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD", BMD, 2013, pp.14, 29~
- Luce LN, "MLPA analysis of an Argentine cohort of patients with dystrophinopathy:association of intron breakpoints hot spots with STR abundance in DMD gene", J Neurol Sci, 365, pp.22~30 (2016)
- Murugan S, "Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis", Indian J Med Res, 132, pp.303~311 (2010)
- Dey S, "Genetic and clinical profile of patients of Duchenne muscular dystrophy:experience from a tertiary care center in Eastern India", Indian Pediatr, 52, pp.481~484 (2015)
- Swaminathan B, "Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in Southern India", Neurol India, 57, pp.734~738 (2009)
- Rao MV, "Duchenne", Becker muscular dystrophy:a report on clinical, biochemical, and genetic study in Gujarat population, India, 2014, pp.17, 303~307
- Manjunath M, "A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study", Neurol India, 63, pp.58~62 (2015)
- Wang X, "Similarity of DMD gene deletion and duplication in the Chinese patients compared to global populations", Behav Brain Funct, 4, pp.20~ (2008)
- 이보련, "Genetic Analysis of Dystrophin Gene for Affected Male and Female Carriers with Duchenne", Becker Muscular Dystrophy in Korea, 2012, pp.27(3), 274~280[DOI]
- Hwa HL, "Multiplex ligation-dependent probe amplification identification of deletions and duplications of the Duchenne muscular dystrophy gene in Taiwanese subjects", J Formos Med Assoc, 106, pp.339~346 (2007)
- Tuffery-Giraud S, "Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase", Hum Mutat, 30, pp.934~945 (2009)
- Magri F, "Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up", J Neurol, 258, pp.1610~1623 (2011)
- White SJ, "Duplications in the DMD gene", Hum Mutat, 27, pp.938~945 (2006)
- Hu XY, "Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination", EMBO J, 10, pp.2471~2477 (1991)
- Zhang Z, "Tandem duplications of two separate fragments of the dystrophin gene in a patient with Duchenne muscular dystrophy", J Hum Genet, 53, pp.215~219 (2008)
- Hattori N, "Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy", Neuromuscul Disord, 9, pp.220~226 (1999)
- Morrone A, "Asymptomatic dystrophinopathy", Am J Med Genet, 69, pp.261~267 (1997)
- Winnard AV, "Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production", Am J Hum Genet, 56, pp.158~166 (1995)
- Gangopadhyay SB, "Dystrophin in frameshift deletion patients with Becker muscular dystrophy", Am J Hum Genet, 51, pp.562~570 (1992)
- Koenig M, "The molecular basis for Duchenne versus Becker muscular dystrophy:correlation of severity with type of deletion", Am J Hum Genet, 45, pp.498~506 (1989)
- Nicolas A, "Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database", Orphanet J Rare Dis, 7, pp.45~ (2012)
- Nicolas A, "Becker muscular dystrophy severity is linked to the structure of dystrophin", Hum Mol Genet, 24, pp.1267~1279 (2015)
- Finsterer J, "The heart in human dystrophinopathies", Cardiology, 99, pp.1~19 (2003)
- Nigro G, "Mutation of dystrophin gene and cardiomyopathy", Neuromuscul Disord, 4, pp.371~379 (1994)
- Bastaki LA, "Genotype phenotype correlation among patients with dystrophinopathies", Alex J Pediatr, 13, pp.365~371 (1999)